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Introduction
Idiopathic pulmonary arterial hypertension (IPAH) is a progressive and fatal disease with a 5 year survival rate of only 34% (McLaughlin et al., 2009) . Sustained pulmonary vasoconstriction and vascular remodelling characterized by concentric wall thickening and lumen obliteration of small-sized and medium-sized pulmonary artery (PA) are the major causes of the elevated pulmonary vascular resistance and pulmonary arterial pressure (PAP) in patients with IPAH (Kuhr et al., 2012; Tuder et al., 2013; Sakao et al., 2015) . Increased cytosolic free Ca 2+ concentration ([Ca 2+ ] cyt ) in PA smooth muscle cells (PASMCs) is an important trigger for pulmonary vasoconstriction and a necessary stimulus for pulmonary vascular remodelling by increasing PASMC proliferation and migration. Thus, enhanced Ca 2+ signalling in PASMC is an important therapeutic target for developing novel treatments for pulmonary hypertension (PH).
Chloroquine is mostly known for its use in the treatment for Plasmodium vivax malaria (White, 1996) but it has also been used to treat autoimmune disorders such as rheumatoid arthritis and systemic lupus erythematosus (Solomon and Lee, 2009; Rainsford et al., 2015) . Chloroquine is a weak base that can increase the pH in lysosomal lumens, which disrupts lysosomal enzymes, thereby inhibits autophagy (Klionsky et al., 2016) . Autophagy is involved in several diseases including pulmonary arterial hypertension (PAH) (Jin and Choi, 2012) . Under disease conditions, cells are reliant on autophagy for survival. Therefore, inhibition of autophagy by treatment with chloroquine leads to increased apoptosis. In a recent study, Long et al. (2013) found that in rats treated with monocrotaline (MCT), the induction of PH was associated with increased expression of markers associated with autophagy including LC3B-II, ATG5 and p62. Chloroquine treatment prevented pulmonary vascular remodelling and inhibited the development of MCT-induced PH. Furthermore, chloroquine inhibited autophagy and proliferation and increased apoptosis in PASMC in MCT-PH rats both in vitro and in vivo (Long et al., 2013) .
In addition to its anti-autophagic effects, chloroquine induced vasodilation and decreased BP following treatment for malaria in humans (Looareesuwan et al., 1986; Anigbogu et al., 1993) and animals (Musabayane et al., 1994; McCarthy et al., 2016) . In thoracic aortas precontracted by noradrenaline or high K + , treatment with chloroquine resulted in a concentration-dependent relaxation (Aziba and Okpako, 2003) . Furthermore, vasodilatation following chloroquine was associated with blockade of L-type voltage-dependent Ca 2+ channels (VDCCs) (Manson et al., 2014; Sai et al., 2014) . A recent study found that chloroquine induced relaxation in human PAs precontracted by the thromboxane A 2 analogue U46619 and phenylephrine (Manson et al., 2014) . Chloroquine also induced bronchodilation (Deshpande et al., 2010; Pulkkinen et al., 2012; Zhang et al., 2013; Tan and Sanderson, 2014) .
Chloroquine is bitter tasting and an agonist of the G-protein-coupled bitter taste receptor type 2 (TAS2R). Bronchodilation is mediated through canonical TAS2R signalling that initially results in a transient increase in [Ca 2+ ] cyt , which subsequently activates the largeconductance Ca 2+ -activated K + (BK) channels and enhances K + efflux leading to membrane hyperpolarization and closure of VDCC (Deshpande et al., 2010) . Chloroquine also induced membrane hyperpolarization and inhibited L-type VDCC in airway smooth muscle cells, as observed in thoracic aorta (Sai et al., 2014) . This blockage of L-type VDCC ultimately leads to an overall decrease in Ca 2+ influx and bronchodilation or airway smooth muscle relaxation (Zhang et al., 2013) . These studies indicated that chloroquine could induce smooth muscle relaxation through activation of BK channels and/or inhibition of VDCC. However, the mechanism by which chloroquine inhibits pulmonary vasoconstriction remains uncertain. In this study, we have found that short-term (2-15 min) and long-term (24-48 h) treatment with chloroquine had different effects. The short-term treatment rapidly caused relaxation in isolated PA, decreased PAP in isolated perfused and ventilated lung, reduced whole-cell Ba 2+ currents through VDCC in PASMC and inhibited store-operated Ca 2+ entry (SOCE) and ATP-induced Ca 2+ entry in PASMC, but shortterm treatment of PASMC with chloroquine did not affect autophagy. However, long-term treatment of PASMC with chloroquine, did inhibit autophagy and markedly inhibited PASMC proliferation. In this study, we performed in vitro, ex vivo and in vivo experiments to investigate the potential mechanisms involved in the beneficial effects on PH, mediated by chloroquine.
Medical University and the University of Arizona. Animal studies are reported in compliance with the ARRIVE guidelines (Kilkenny et al., 2010; McGrath and Lilley, 2015) . All animals were housed in standard plastic cages on sawdust bedding in an air-conditioned room at 22 ± 1°C under lighting controls with 12 h light and dark cycles. Standard mouse chow and tap water were provided ad libitum.
For the hypoxia-induced PH (HPH) rat model, adult male Sprague Dawley (SD) rats (175-250 g) were exposed to hypoxia (10% O 2 ) for 21 days as previously described (Wang et al., 2006; Das et al., 2012) . For Sugen 5416/hypoxia (SuHx) PH rat model, SD rats were either injected s.c. with 20 mg·kg À1 SU5416 (Sigma-Aldrich, St. Louis, MO, USA) or vehicle, exposed to hypoxia conditions for 3 weeks (10% O 2 ) and returned to normoxia (21% O 2 ) for 2 weeks. Normoxic controls were kept in room air only (21% O 2 ) for a total of 5 weeks. For the HPH model, rats were housed in sets of three animals per cage and randomly assigned to four different experimental groups (n = 6 each group): (i) normoxic control, (ii) normoxia + chloroquine (CHQ), (iii) hypoxic control and (iv) hypoxia + CHQ. For SuHx model, rats were also randomly assigned to four different experimental groups: (i) normoxia for 5 weeks, (ii) Sugen/hypoxia for 3 weeks, (iii) Sugen/hypoxia for 3 weeks + normoxia for 2 weeks and (iv) Sugen/hypoxia for 3 weeks + CHQ/normoxia for 2 weeks. Chloroquine (C6628, Sigma-Aldrich) was given to the rats by i.p. injection at 50 mg·kg À1 ·day À1 for 21 days, while control groups of animals received equivalent amounts of saline.
Haemodynamic evaluation and lung histochemistry experiment
Following hypoxic exposure, rats were anaesthetized with ketamine/xylazine before haemodynamic measurements. Right ventricular systolic pressure (RVSP) and right ventricular hypertrophy were measured using the same method as we described previously (Lu et al., 2010) . Blood was collected into EDTA-treated tubes to quantify haematocrit. The blood was placed in a long capillary tube and centrifuged in a microhaematocrit centrifuge (TG12, Xiangzhi Centrifuge Instrument Co., Changsha, China) at 14 730 × g for 15 min. The HCT level reached by the column of erythrocytes was determined with a scale reader. Paraffin-embedded lung cross sections at a thickness of 5 μm were stained by haematoxylin and eosin (H&E) and visualized according to common histopathological procedures. PA wall thickness or the thickness of the smooth muscle layer of distal small PA (50-100 μm) was measured in H&E images of lung cross sections using the Image-Pro Plus software.
Culture of PASMC
Human PASMCs were acquired from Lonza (Walkersville, MD, USA) and cultured in SmGM-2 medium (Lonza) supplemented with SmGM-2 SingleQuots (Lonza) according to the manufacturer's instruction. The cells at passages 5-10 were used for the experiments. The human PASMCs were incubated and maintained in a humidified atmosphere of 5% CO 2 and 95% air at 37°C.
Measurement of cell proliferation and cytotoxicity
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, from Sigma-Aldrich) assay was used to quantify the level of cell proliferation in PASMC. For determining the short-term treatment effect of chloroquine, PASMCs were incubated with different concentrations of chloroquine (0, 10, 20, 50 , 100 and 200 μM) for 15 min. Following the treatment, PASMCs were washed with fresh medium to remove chloroquine and further incubated for 48 h after exposure. For determining the long-term treatment effect of chloroquine, PASMCs were incubated with different concentrations of chloroquine (0, 1, 5, 10, 20, 50 
Immunocytochemistry
Cells grown on coverslips in chamber slides were fixed in 4% paraformaldehyde for 20 min, permeabilized using 0.2% Triton-X-100 for 10 min and incubated overnight with an anti-LC3B antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA, 1:1000). The specimens were subsequently incubated with Alexa Fluor 488 (1:1000) secondary antibody for 1 h in the dark. DAPI was utilized to stain the nucleus. Images were captured using a fluorescence microscope (Olympus, Tokyo, Japan) and were photographed using a digital camera. The percentage of PASMC containing more than five LC3 dots was used as LC3-positive cells to quantify autophagy. Selected fields with a minimum of 100 cells were scored.
Western blot analysis
Cells were lysed using ice-cold RIPA buffer with freshly added protease inhibitor cocktail (Roche, Mannheim, Germany). PASMCs were incubated in lysis buffer for 20 min on ice and centrifuged at 12 000× g for 30 min at 4°C. Protein concentration was determined from the collected supernatant, followed by mixing and boiling samples in Laemmli buffer supplemented with 2-mercaptoethanol (Basal Medium Eagle, 
Measurement of isometric tension in isolated rings of rat PA
The intrapulmonary arteries were carefully dissected out from male SD rats under anaesthesia, with a dissecting microscope. Freshly isolated PA rings (2 mm long) were suspended between two tungsten wires to record isometric tension. The two tungsten wires were inserted into the lumen of the PA and fixed respectively to a force transducer and a micrometer and mounted on wire myographs (DMT, Aarhus, Denmark). PA rings were superfused with 5 mL Krebs solution including (in mM): 138 NaCl, 1.8 CaCl 2 , 4.7 KCl, 1.2 MgSO 4 , 1.2 NaH 2 PO 4 , 5 HEPES and 10 glucose (pH 7.4), maintained at 37°C and aerated with 95% O 2 /5% CO 2 . The passive resting tension was set and maintained at an optimal tension of 300 mg. The rings were allowed to stabilize at the resting tension for approximately 1 h before experimentation. After the 1 h equilibration, the isolated PA rings were stimulated twice with 60 mM K + -containing solution (60K) to stabilize the vessel and obtain a stable contractile response before further experimentation. The baseline tension of the isolated PA rings usually becomes stable after three challenges with a 60K-containing solution. The ring was considered non-viable if the ring could not provide reproducible contractions to 60K or phenylephrine, or because of poor recording quality. The ring was also excluded if it gave poor responses to phenylephrine, due to PA damage. For relaxation studies, rings were contracted with phenylephrine or high K + solutions containing 40 mM (40K) or 80 mM (80K) of KCl. Selected experiments were performed using vessels with either intact or denuded endothelium. Endothelium was denuded mechanically using forceps before placing the PA rings on tungsten wires. Endothelium-dependent vasodilation was assessed using ACh (endothelium-dependent relaxation), while endothelium-independent vasodilation was assessed using sodium nitroprusside (SNP, endothelium-independent relaxation) after pre-constriction of the artery with 1 μM phenylephrine. In some experiments, the rings were treated with L-NG-nitroarginine methyl ester (L-NAME), indomethacin, apamin, paxilline, tetraethylammonium (TEA) and charybdotoxin (ChTX) for 30 min and continuously treated during the experiment to test the effect of chloroquine on phenylephrine-induced contraction of the PA rings. Data are expressed as % relaxation of phenylephrineinduced pre-constriction.
Measurement of whole-cell inward currents through VDCC in PASMC
Ca 2+ currents were recorded with the conventional wholecell configuration of the patch-clamp technique using an Axopatch 200B amplifier and a Digidata 1440A acquisition system (Molecular Devices, Sunnyvale, CA, USA). Lowresistance patch pipettes (3-4 MΩ) made from borosilicate glass were fabricated on an electrode puller (model P-97, Sutter Instrument, Novato, CA, USA) and fire polished with a microforge (MF-63, Narishige Scientific Instrument Laboratories, Tokyo, Japan) for whole-cell current recordings. Command voltage pulse protocols and data acquisition were performed using pClamp 10.7 (Molecular Devices). Currents were filtered at 1-2 kHz and digitized at 2-5 kHz. The extracellular solution for recording the Ca 2+ currents contained the following (in mM): 115 NaCl, 10 BaCl 2 , 4.7 KCl, 0.5 MgCl 2 , 10 HEPES and 10 glucose (adjusted to pH 7.4 with NaOH). Cells were continuously superfused in the recording chamber with the extracellular solution at a flow rate of approximately 1.2 mL·min À1 . The pipette solution for the Ca 2+ current recordings contained the following (in mM): 130 CsCl, 10 EGTA, 5 Mg-ATP and 10 HEPES (adjusted to 7.2 with CsOH). The P/4 subtraction protocol in the pClamp software was used for the subtraction of leak currents. All electrophysiological recordings were attained at room temperature (22-24°C).
Data and statistical analysis
The data and statistical analysis comply with the recommendations on experimental design and analysis in pharmacology (Curtis et al., 2015) . Data are expressed as mean ± SEMand analysed for statistical significance between two or among multiple groups using the unpaired Student's t-test or one-way ANOVA of the Sigma Plot statistical package (SigmaPlot 11.0; Systat Software, Inc., Chicago, IL, USA). Differences between means were considered to be significant at P < 0.05.
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Materials
All drugs were obtained from Sigma Chemical unless otherwise stated. Chloroquine, ACh and SNP were prepared as concentrated stock solutions in saline. TEA was dissolved in distilled water as a stock solution. Paxilline (Cayman Chemical Company, Ann Arbor, MI, USA), ChTX, cyclopiazonic acid (CPA), L-NAME and indomethacin were prepared as stock solutions in DMSO. Chloroquine, ACh, SNP and TEA were aliquoted at 4°C, and other drug stock solutions were aliquoted and kept frozen at À20°C until use.
Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to corresponding entries in http://www. guidetopharmacology.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Southan et al., 2016) , and are permanently archived in the Concise Guide to PHARMACOLOGY 2015/16 (Alexander et al., 2015a,b,c) .
Results
Chloroquine causes endothelium-independent relaxation in rat PA rings precontracted with phenylephrine or high K + PA rings were isolated from 7-to 9-week-old rats. Contraction of the isolated PA ring was induced with 1 μM phenylephrine. After a steady-state contraction had been achieved, chloroquine was added cumulatively to the organ bath to yield final concentrations of 0.1, 1, 10, 50, 100 and 200 μM. We observed that chloroquine induced a concentration-dependent relaxation of the PA ring with an EC 50 value of 73 ± 2.9 μM ( Figure 1A , B). Following treatment with the highest concentration (200 μM) of chloroquine, we observed 97.2% relaxation. After relaxation in the presence of 200 μM chloroquine, the PA rings were washed and then treated again with 1 μM phenylephrine to achieve a steady-state contraction. The second round of treatment with 200 μM chloroquine resulted again in 97% relaxation ( Figure 1C ) indicating that chloroquine reversibly induced relaxation in PA rings. Furthermore, we found that the chloroquine-mediated relaxation in PA rings precontracted with 80 mM K + (63 ± 1.6%) was greater than in the rings precontracted with 40 mM K + (35 ± 1.9%; P < 0.05) ( Figure 1D , E). Next, we evaluated whether chloroquine-mediated vasodilation of PA rings was dependent on endothelial cells. To test this, we utilized and compared the endothelium-intact PA rings and the endothelium-denuded PA rings. Endothelium was considered intact if, following pre-constriction with 1 μM phenylephrine, 1 μM ACh relaxed the PA ring by greater than 80% of the maximal contraction ( Figure 2A ) and endothelium was considered functionally removed if the relaxation to 1 μM ACh was less than 20% of the maximal contraction and complete relaxation of pre-constricted PA rings was obtained with 10 μM SNP ( Figure 2B ). Treatment with 200 μM chloroquine inhibited phenylephrine-induced contraction in endothelium-intact or endothelium-denuded PA rings to the same extent ( Figure 2A , B, C).
To further confirm that chloroquine-induced PA relaxation was not dependent on endothelial cells, we inhibited the production of NO or PGI 2 in the endothelium using the NOS inhibitor, L-NAME and the PGI 2 synthesis inhibitor, indomethacin (Chennupati et al., 2013) . As shown in Figure 2D , chloroquine (200 μM) relaxed PA rings pretreated with L-NAME (100 μM for 30 min) or indomethacin (10 μM for 30 min), to the same extent under all three conditions (control, treated with INDO or treated with L-NAME ( Figure 2E ). Figure 3A ). Treatment with chloroquine decreased the amplitude of SOCE induced by passive store depletion using CPA in human PASMC by about 20 % ( Figure 3B ). To examine the potential effect of chloroquine on ROCC, we used ATP as the extracellular agonist to induce ROCE. ATP binds to purinergic receptors at the plasma membrane, resulting in the production of IP 3 and diacylglycerol (DAG). DAG is a known second messenger that directly opens ROCC to induce ROCE, while IP 3 activates the IP 3 receptors in the SR producing active Ca 2+ release and resulting in SOCE. In control human PASMC, extracellular application of ATP caused a transient increase in [Ca 2+ ] cyt due to both ROCE and SOCE ( Figure 3C ). Treatment with chloroquine inhibited the amplitude of the ATP-induced increases in [Ca 2+ ] cyt in human PASMC, by about 25%. Also, we performed the same experiments in HEK293 cells transiently transfected with the gene for the TRPC6 cation channel (Supporting Information Figure S1 ). Extracellular application of chloroquine significantly inhibited the ATP-induced increase in TRPC6-transfected cells.
Chloroquine inhibits
To investigate the direct effect of chloroquine on VDCC, we measured the peak inward current that was evoked by a +10 mV depolarizing pulse from a holding potential of À70 mV using whole-cell configuration of the patch-clamp technique. In this experiment, we used Ba 2+ as the charge carrier to elicit inward currents through L-type VDCC (Ca v 1.x channels) and the peak currents through L-VDCC were normalized to cell capacitance to determine the current density (pA/pF). The whole-cell inward currents through VDCC were almost abolished when cells were superfused with an external solution containing 200 μM chloroquine ( Figure 3F ,G) and this inhibition was reversed after washing ( Figure 3F ).
Activation of the large-conductance Ca 2+ -activated K + channels is not required for chloroquine-mediated PA relaxation Zhang et al., (2012) have shown that the BK channels are activated by chloroquine to exert its relaxing effect on airway smooth muscle. To investigate whether activation of BK channels and voltage-gated K + (K v ) channels were involved in chloroquine-mediated pulmonary vasodilation, we used paxilline and ChTX to block BK channels and TEA to block K v channels in the PA tension experiments. As shown in Figure 4 , blockade of BK and K v channels using 5 μM paxilline, 10 mM TEA or 100 nM ChTX had a negligible effect on the relaxation induced by 200 μM chloroquine in PA rings precontracted with 1 μM phenylephrine ( Figure 4A , B).
Chloroquine attenuates pulmonary vasoconstriction induced by high K + or alveolar hypoxia
Using an ex vivo model, we also investigated whether chloroquine directly affects PAP in isolated perfused and ventilated mouse lung. First, we superfused this lung preparation with Figure 5A ). Pretreatment of the isolated lung by continuous perfusion of chloroquine (200 μM) through the PA almost totally prevented the 40K-induced increases in PAP. The inhibitory effect of chloroquine was reversed upon washout ( Figure 5A, B) . Furthermore, we examined the effect of chloroquine on the alveolar hypoxia-induced increase in PAP or acute HPV in the isolated perfused and ventilated lung. Alveolar hypoxia was established by ventilating the lung with a hypoxic gas mixture (1% O 2 in N 2 ). As shown in Figure 5C , alveolar hypoxia rapidly and reversibly induced pulmonary vasoconstriction and increased PAP. Addition of chloroquine (200 μM) to the pulmonary perfusion attenuated the hypoxia-induced increases in PAP ( Figure 5C ) and this effect of chloroquine was reversible.
Expressino of the mRNA for TAS2R in human PASMC, rat PA and mouse PA In addition to its anti-malarial, anti-autophagic and vasodilator effects, chloroquine has been reported to activate TAS2R in various tissues and cells. We conducted a series of RT-PCR experiments to define the TAS2R transcripts in rat/mouse PA and human PASMC. Based on NCBI.com, we first identified and matched the gene synonym of human TAS2R (hTAS2R), rat TAS2R (rTAS2R) and mouse TAS2R (mTAS2R). We then selected seven matched human, rat and mouse TAS2R subtypes that are suggested to be activated by chloroquine for our RT-PCR experiments (Supporting Information  Table S1 ). Using the specific primers (Supporting Information  Tables S2-S4) , we found all seven TAS2R isoforms (hTAS2R3, hTAS2R4, hTAS2R7, hTAS2R10, hTAS2R14, hTAS2R39 and hTAS2R40) are expressed in human PASMC (Supporting Information Figure S2) ; however, rTAS2R107 (hTAS2R10 and mTAS2R110) in rat PA and mTAS2R108 (hTAS2R4 and rTAS2R108) in mouse PA were not detectable. These data indicate that most of the chloroquine-sensitive TAS2R are expressed in human, rat and mouse PASMC. However, two TAS2R isoforms, rTAS2R107 and mRAS2R108, are differentially expressed in rat and mouse PA in comparison with human PASMC.
Short-term treatment with chloroquine has no effect on autophagy or proliferation in human PASMC Chloroquine inhibits autophagy through lysosome alkalinization, which interferes with the function of the pH-sensitive lysosomal enzymes. Abundant LC3-II and increased expression of P62 protein in cells can be used to assess the levels of inhibition of autophagy, after chloroquine treatment. We first assessed the effects of short-term treatment (2-15 min) with chloroquine (up to 200 μM) on autophagy and cell viability in human PASMC. As shown in Figure 6 , short-term treatment of human PASMC with 200 μM chloroquine did not affect the protein level of LC3-II and P62 ( Figure 6A, B) , or the formation of LC3B dots ( Figure 6C, D) . Also, as shown in Figure 6E , short-term (5 and 15 min) treatment of PASMC with chloroquine (20-200 μM) did not decrease the number of living cells (% of total cells). Proliferation of human PASMC was similarly not affected by short-term (15 min) treatment of human PASMC with chloroquine (10-200 μM), using the MTT assay ( Figure 6F ).
Long-term treatment with chloroquine inhibits autophagy and proliferation in human PASMC
We then investigated the effects of long-term (24h) treatment with chloroquine on autophagy in human PASMC and found an increased expression of P62 and LC3B-II ( Figure 7A , B), with 20 μM chloroquine. This treatment also increased the number of LC3-positive human PASMC, defined as cells with more than 5 LC3 dots ( Figure 7C, D) . In terms of proliferation of human PASMC, long-term treatment (for 48h) with chloroquine (1-100μM) concentration-dependently decreased MTT activity.These effects were first significant at 20 μM and reached a maximum at 100 μM ( Figure 7E ).
Chloroquine attenuates experimental pulmonary hypertension models in rats
To determine whether chloroquine can prevent the development of PH or inhibit the progression of established PH in HPH or SuHx reversal rats model. In the HPH model, we examined and compared (a) RVSP; (b) the ratio of the weight of right ventricle (RV) and the weight of left ventricle (LV) and septum (S) [RV/(LV + S)], also referred to as the Fulton Index; and (c) the ratio of the weight of RV to body weight (RV/BW), HCT and the BW change in normoxic control rats treated with vehicle (Nor) and chloroquine (50 mg·kg À1 , i.p., daily) (Nor + CHQ) as well as hypoxic rats treated with vehicle (Hyp) and chloroquine (50 mg·kg À1 , i.p., daily) (Hyp + CHQ). After 3 week exposure to hypoxia, rats exhibited significantly increased RVSP and RV hypertrophy or increased RV/(LV + S) and RV/BW. Treatment with chloroquine (50 mg·kg À1 , i.p., daily, for 3 weeks) prevented the increases in RVSP, RV/(LV + S) and RV/BW in rats exposed to hypoxia (Supporting Information Table S5 and Figure 8A -C). Additionally,the haematocrit was also markedly increased in rats with HPH, compared with that in normoxic control rats (Supporting Information Table S5 and Figure 8D ) and this hypoxia-induced increase in haematocrit was also inhibited by the treatment with chloroquine (Supporting Information Table S5 and Figure 8 ). In these experiments, chloroquine did not affect any of the parameters measured in the rats exposed to normoxia In the model of SuHx, combination of SU5416 with 3 weeks of hypoxia significantly increased RVSP, RV/(LV + S) and RV/BW (Supporting Information Table S6 and Figure 9 ). After 3 weeks of hypoxia and 2 weeks of follow-up in normoxia, RVSP, RV/(LV + S) and RV/BW were further increased compared with the corresponding values after 3 weeks of hypoxia exposure, alone. However, after 3 weeks of hypoxia and 2 weeks treatment with chloroquine in normoxia, this further increase in RVSP and RV hypertrophy was blocked (Supporting Information Table S6 and Figure 9 ).
Histological examination revealed that chronic exposure to hypoxia significantly increased the wall thickness of the small PA (Supporting Information Table S5 and Figure 8E, F) . Treatment of hypoxic rats with chloroquine (Hyp + CHQ, 50 mg·kg À1 , i.p., daily for 3 weeks) significantly reduced the small PA wall thickness, in comparison with the hypoxia only (Hyp) group of rats (Supporting Information Table S5 and Figure 8 ). Chloroquine treatment under normoxic conditions (Nor + CHQ) did change any of the haematological ( Figure 8D ) and histological ( Figure 8E /F) parameters (Supporting Information Table S5 ). In all in vivo experiments, the BW of all rats was measured every other day during the continuous 21 day exposure to normoxia or hypoxia. The i.p. injection of chloroquine (50 mg·kg À1 , daily) resulted in a slight decrease in BW in Nor + CHQ and Hyp + CHQ groups. however, the ratio of the liver weight/BW, the kidney weight/BW and the spleen weight/BW was not significant between Nor and Nor + CHQ groups and between Hyp and Hyp + CHQ groups (data not shown). 
Discussion
The results from the present study demonstrated that (i) chloroquine induced endothelium-independent pulmonary vasodilation in a concentration-dependent manner, and blockade of the BK channels and voltage-gated K + channels negligibly affected the chloroquine -induced relaxation of the PA; (ii) chloroquine rapidly and reversibly induced vasorelaxation in PA rings pre-contracted by 80 mM K + -containing solution and reduced whole-cell inward currents through L-type VDCC in PASMC; (iii) chloroquine significantly inhibited SOCE and ROCE in PASMC; (iv) perfusion of chloroquine through the pulmonary circulation significantly inhibited alveolar hypoxia-induced pulmonary vasoconstriction in isolated perfused and ventilated mouse lungs; (v) short-term (2-15 min) treatment of human PASMC with chloroquine (up to 200 μM) did not affect cell autophagy and cell viability in PASMC, while long-term (24-48 h) treatment with chloroquine (≥20 μM) inhibited autophagy and attenuated serum-associated PASMC proliferation; and (vi) i.p. injection of chloroquine (50 mg·kg À1 , daily, for 3 weeks) significantly inhibited the development and progression of HPH in rats. These data provide strong evidence that chloroquine is a potent, endotheliumindependent, pulmonary vasodilator that relaxes PA by directly and/or indirectly by inhibiting various Ca 2+ channels (e.g. VDCC, SOCC and ROCC) in PASMC. The therapeutic potential of chloroquine in the treatment of PAH and other forms of PH is based on its vasodilator effect on PA smooth muscle as well as its anti-autophagic and anti-proliferative effects in PASMC. Chloroquine (Aralen ™ , C 18 H 26 CIN 3 ), 4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamine, is a synthetic compound, best known for treatment of malaria (Pascolo, 2016) . Chloroquine also inhibits autophagy, by increasing lysosomal pH and disrupting lysosomal enzymes so cells under stress cannot activate the autophagy pathway. A recent study showed that prolonged treatment (≥24 h) of animals with chloroquine decreased markers of autophagy, inhibited lysosomal degradation of BMPR-II, inhibited PASMC proliferation and ameliorated MCT-induced PH in rats (Long et al., 2013) . Consistent with the anti-autophagic and anti-proliferative effects of chloroquine, we also found that short-term (≤15 min) treatment with chloroquine had no effect on PASMC autophagy and proliferation, but exerted significant and rapid vasorelaxant effects on PA by inhibiting Ca 2+ influx in PASMC. The acute pulmonary vasodilator effect of chloroquine seemed to be independent of its anti-autophagic effect. Chloroquine also has a bitter taste and it can activate the bitter taste receptor (TAS2R), a seven transmembrane domain GPCR. Several bitter taste receptors are expressed in airway smooth muscle cells (Deshpande et al., 2010) . TAS2R3, TAS2R10, TAS2R39 and TAS2R7 are reported to respond to chloroquine (Sainz et al., 2007; Meyerhof et al., 2010) . We found that mRNA of TAS2R3, TAS2R10, TAS2R39 and TAS2R7 are expressed in human PASMC, rat PA and mouse PA. Treatment of airway smooth muscle cells in vitro with chloroquine results in an increase in [Ca 2+ ] cyt (Deshpande et al., 2010; Zhang et al., 2012) that would be expected to induce contraction. However, the authors actually observed smooth muscle relaxation and dilation of the airways. To better understand the mechanism behind this paradox, two separate groups tested the hypothesis that increased [Ca 2+ ] cyt triggers the opening of BK channels resulting in membrane hyperpolarization. Deshpande et al. (2010) reported that chloroquine treatment of isolated human airway smooth muscle cells led to membrane hyperpolarization via a Gβγ-dependent, PLCβ-dependent and IP 3 receptor-dependent manner. In contrast, Zhang et al. (2012) demonstrated that bitter-tasting compounds, including chloroquine inhibited BK channel activity. However, it is not clear why and how BK channel inhibition led to the observed bronchodilation. These discrepant effects of chloroquine on BK channels are most likely due to differences in species (human vs. mouse), tissue (airway vs. vessel) and cell phenotype (freshly dispersed cells vs. primary cultured cells). Activation of BK channels is known to play a major role in PA relaxation (Dong et al., 2016) . However, our study showed that BK and non-selective K + channel blockers did not significantly inhibit chloroquine-mediated relaxation of the PA.
Intracellular Ca 2+ is one of the most important regulators of cell function in PASMC. The increase in [Ca 2+ ] cyt is known to stimulate cell contraction, migration and proliferation (Somlyo and Somlyo, 1994; Mandegar et al., 2004; Hill et al., 2006) . Given that chloroquine does not affect Ca 2+ extrusion (Tan and Sanderson, 2014) , we hypothesized that this compound might induce PA relaxation by inhibiting Ca 2+ -permeable channels in PASMC. There are at least three families of Ca 2+ -permeable channels in PASMC: (i) SOCCs, (ii) ROCCs and (iii) VDCCs. PASMC (Mandegar and Yuan, 2002; Hall et al., 2009) . Sai et al. (2014) observed that chloroquine resulted in vasorelaxation in aortas precontracted with a high K + -concentrations, while pretreatment with chloroquine inhibited the high K + -induced increases in [Ca 2+ ] cyt in rat thoracic aortic smooth muscle cells. In the current study, we found that chloroquine rapidly and reversibly caused vasorelaxation in PA rings precontracted by 40K and 80K and inhibited 40K-induced increases in PAP in isolated perfused and ventilated lungs. These data suggest that blockade of VDCC is an important mechanism by which chloroquine induces pulmonary vasodilation. In PA rings constricted by 40K, the equilibrium potential for K + (E K ) is predicted to be approximately À31 mV based on the Nernst equation. Opening of K + channels would shift E m toward the E K (À31 mV) and away from the activation threshold of VDCC (the window current of L-type VDCC is approximately À25 to +15 mV) (Nelson et al., 1990; Fleischmann et al., 1994; Ko et al., 2013) , which results in closure of VDCC. In PA rings constricted by 80K, the E K is predicted to be approximately À14 mV. Activation of K + channels would shift E m toward the E K (À14 mV), which is above the activation threshold of VDCC; this prevents VDCC closure and results in vasodilation. In the current study, we demonstrated that chloroquine rapidly relaxed PA rings precontracted by 40K or 80K and significantly inhibited the 40K-induced increase in PAP in isolated perfused and ventilated lungs. These data strongly indicate that chloroquine blocks VDCC in PASMC, inhibits Ca 2+ influx and elicits pulmonary vasodilation. Our patch-clamp experiments suggested that chloroquine may directly block L-type VDCC in human PASMC, as it significantly and reversibly attenuated the maximal inward current. Consistent with our findings, chloroquine inhibited VDCC via Gβγ and Gα 1 signalling pathways in airway smooth muscle cells (Zhang et al., 2013) . Thus, the chloroquine-mediated blockade of VDCC could be a potential mechanism involved in inhibiting agonist-induced PA contraction. Alveolar hypoxia-induced pulmonary vasoconstriction (HPV) is an important physiological mechanism that directs blood flow from poorly ventilated regions to well-ventilated areas in the lungs to maximize oxygenation of the venous blood in the pulmonary circulation. Persistent HPV in patients with obstructive lung diseases and chronic mountain sickness may lead to sustained pulmonary vasoconstriction, vascular remodelling and, eventually, to chronic PH. Alveolar HPV requires an influx of extracellular Ca 2+ through various Ca 2+ channels in PASMC , specifically, Ca 2+ influx through VDCC opened by hypoxia-mediated membrane depolarization (Yuan et al., 1993; Wan et al., 2013) and Ca 2+ influx through SOCC and ROCC (Wang et al., 2005; Wang et al., 2006) . It has been demonstrated that upregulated Ca V 1.2 or Ca V 3.2 channels and TRPC1and TRPC6 channels (Wang et al., 2006) in PASMC contribute to increased HPV in the development of HPH.
Overexpression of TRPC6 also increased [Ca 2+ ] cyt in pulmonary venous and arterial SMC exposed to chronic hypoxia (Lin et al., 2004; Peng et al., 2013; Peng et al., 2015) . Using the isolated perfused and ventilated lungs, we found that adding chloroquine to the perfusing solution rapidly and reversibly inhibited the alveolar hypoxia-induced increase in PAP ( Figure 5 ). The inhibitory effect of chloroquine on acute HPV is due most likely to its blockade of VDCC, ROCC and SOCC in PASMC. Further studies are needed to identify the particular channels targeted by chloroquine to exert its inhibitory effect on acute HPV and define the cellular mechanisms involved in chloroquine-mediated inhibition of HPV. Our results showed that chloroquine inhibited not only high K + -mediated PA contraction but also phenylephrineinduced pulmonary vasoconstriction. In PASMC, we also demonstrated that chloroquine significantly inhibited CPAmediated SOCE and ATP-mediated ROCE ( Figure 3A -E), suggesting that chloroquine may directly or indirectly block SOCC and ROCC in PASMC. Chloroquine inhibits IP 3 receptors (Tan and Sanderson, 2014) and decreases Ca 2+ influx through TRPC3 and STIM/Orai channels (Zhang et al., 2014; Xu et al., 2015 Chloroquine inhibits progression of established PH in the SuHx rat model. (A) Representative record of right ventricular pressure (RVP). Rats were given an s.c. injection of 20 mg·kg À1 SU5416 or vehicle, followed by hypoxia (SuHx) for 3 weeks (10% O 2 ) and normoxia for an additional 2 weeks to elicit severe PH. After 3 weeks of hypoxia, the SuHx rats were divided into three groups: hypoxia with no intervention (SuHx3w), vehicle treatment (SuHx3w + Nor2w) and treatment with chloroquine (CHQ; 50 mg·kg À1 ·day À1 ) (SuHx3w + CHQ2w). The normoxic control group was exposed to room air only (21% O 2 ) for a total of 5 weeks (Nor). n = 6 for each group. (B) Summarized data, as means ± SEM, showing the peak value of RVSP in Nor, SuHx3w, SuHx3w + Nor2w and SuHx3w + CHQ2w groups. * P < 0.05, significantly different from Nor; # P < 0.05, significantly dif- depolarization (Gilbert et al., 2016) . In HEK293 cells traniently transfected with the gene encoding TRPC6 channels, chloroquine attenuated the ATP-mediated increase in [Ca 2+ ] cyt (Supporting Information Figure S1 ), indicating that chloroquine may partly block TRPC6 channels, which contribute to forming ROCC and SOCC (Thebault et al., 2005; Albarran et al., 2014) , and thus induce PA relaxation. Further studies are needed to specify the types of cation channels that can be blocked by chloroquine and to define the precise mechanisms by which chloroquine exerts its inhibitory effect on Ca 2+ channels in PASMC.
We noted that the concentration of chloroquine (50 to 200 μM) required for acutely inducing PA relaxation (see Figure 1B ) was much higher than the therapeutic plasma concentration observed in patients (Phillips et al., 1986) . Similar concentrations of chloroquine have been used by other investigators to test its pharmacological effect in different tissues and cells. For example, 3 mM chloroquine was used for experiments in rat thoracic aorta (Sai et al., 2014) , 1 mM in human airway smooth muscle cells and mouse tracheas (Deshpande et al., 2010) , 500 μM in mouse airway smooth muscle cells (Tan and Sanderson, 2014) , 100-300 μM in rat ileum (Jing et al., 2013) and 100 μM in guinea pig aorta (Manson et al., 2014) . We found that chloroquine-mediated PA relaxation started at approximately 20-50 μM and maximized at about 200 μM when this compound was applied to PA rings or to isolated perfused and ventilated lungs) for 2-15 min. The vasodilator effect of chloroquine was rapid in onset (effective within 1-2 min) and reversible (see . In our in vitro experiments, we found that short-term (2, 5 and 15 min) treatment with chloroquine (20, 100 and 200 μM) had neither toxic effect nor antiautophagic and anti-proliferative effects on PASMC (Figure 6 ), whereas long-term (24 and 48 h) treatment with chloroquine inhibited autophagy (20 μM for 24 h) and cell proliferation (20 μM for 48 h) in PASMC (Figure 7 ). These observations imply that chloroquine-mediated pulmonary vasodilation is a separate process from its anti-autophagic effect on PASMC. The cellular mechanisms involved in the therapeutic action of chloroquine for PH include its vasodilator effect (due to blockade of Ca 2+ channels) on the PA, anti-autophagic effect and anti-proliferative effect (due to inhibition of Ca 2+ entry and autophagy) on PASMC.
Indeed, in our in vivo experiments, we showed that i.p. injection of chloroquine (50 mg·kg À1 , daily for 3 weeks) significantly attenuated the development of PH in rats exposed to hypoxia (10% O 2 for 3 weeks). The dose (50 mg·kg À1 ) we chose in the in vivo experiments was similar to the dose used for anti-tumour and anti-angiogenesis studies in tumourbearing mice (Zheng et al., 2009; Jiang et al., 2010; Maes et al., 2014) . This dose of chloroquine, as reported previously, is known to inhibit autophagy and lead to increased expression of p53 resulting in increased cell apoptosis (Amaravadi et al., 2007) . We observed that chloroquine (50 mg·kg À1 daily for 3 weeks) led to an overall loss of BW in both normoxic and hypoxic rats. However, the ratios of liver weight to BW (liver/ BW), kidney weight to BW (kidney/BW) and spleen weight to BW (spleen/BW) were not significantly changed by chloroquine treatment at this dose. Measured PA wall area/vessel area alone is not enough to evaluate PA remodelling due to the heterogeneity of the vessel area and lumen area during constriction or vasodilation. However, the PA wall thickness due to vascular remodelling would not change during acute vascular constriction and vasodilation. We found that PA wall thickness, PA wall area and the ratio of PA wall area to vessel external area were significantly decreased after chloroquine treatment, compared with vehicle under hypoxic conditions in rats, suggestingthat chloroquine attenuated PA remodelling in HPH. In consistent with earlier data (Long et al., 2013) , we also found that chloroquine can inhibit the progression of established PH in the SuHx rat model. Chloroquine is an FDA approved drug that is easy to use and has minimal side effects. As chloroquine has inhibitory effects on the development of PH and was able to reverses established PH, it could be an effective treatment for PAH, in particular for the patients who do not respond to the conventional therapies such as prostacyclin receptor activators, NO-cyclic GMP enhancement or endothelin receptor antagonism. These data indicate that chronic treatment with chloroquine may be an effective and safe therapeutic approach for PH. In summary, our in vitro, ex vivo and in vivo studies all indicate that chloroquine is a potent pulmonary vasodilator that, in combination with its anti-autophagic and antiproliferative effect on PASMC, can significantly attenuate the development and progression of experimental PH in animal models. The cellular mechanisms by which chloroquine induces PA relaxation (and inhibition of PASMC proliferation) may involve blockade of various Ca 2+ channels in PASMC. Zhang CH, Lifshitz LM, Uy KF, Ikebe M, Fogarty KE, ZhuGe R (2013 
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https://doi.org/10.1111/bph.13990 Figure S1 RT-PCR analysis of TAS2R in human PASMC (A), rat pulmonary arteries (B) and mouse pulmonary arteries. Transcripts of seven subtypes of hTAS2Rs (3, 4, 7, 10, 14, 39, 40 ) (A), rTAS2Rs (137, 108, 121, 107, 123, 139, 144 ) (B) and mTAS2Rs (137, 108, 130, 110, 114, 139 140) (C) are identified in human PASMC, rat pulmonary arteries and mouse pulmonary arteries, respectively. ]cyt before (Basal) and after (ATP) extracellular application of ATP in GFPtransfected and Trpc6-transfected cells in the absence (GFP, Trpc6) or presence (Trpc6 + CHQ) of chloroquine. *P < 0.05 vs. Basal. C: Summarized data (mean ± SE) showing ATP-induced increases in [Ca 2+ ]cyt in GFP-transfected cells and Trpc6-transfected cells treated with (Trpc6 + CHQ) or without (Trpc6) chloroquine. *P < 0.05 vs. Control; #P < 0.05 vs. Trpc6. Table S1 The gene synonym between human, rat and mouse TAS2Rs. Table S2 DNA primer sequences for the hTAS2Rs. Table S3 DNA primer sequences for the mTAS2Rs. Table S4 DNA primer sequences for the rTAS2Rs. Table S5 Chloroquine inhibits the development of hypoxiainduced pulmonary hypertension in rats. Table S6 Chloroquine inhibits the progression of established pulmonary hypertension in Sugen5416/hypoxia rat model.
